NCT01302990View on ClinicalTrials.gov

Safety, Tolerability and Immunogenicity of a Plant-Made H1 VLP Influenza Vaccine in Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

July 31, 2011

Study Completion Date

November 30, 2011

Conditions
Flu
Interventions
BIOLOGICAL

Dose given at Day 0

Dose given by intramuscular administration (0.5 mL)

Trial Locations (1)

20850

Accelovance, Rockville

Sponsors

Lead Sponsor

Medicago
All Listed Sponsors
lead

Medicago

INDUSTRY

NCT01302990 - Safety, Tolerability and Immunogenicity of a Plant-Made H1 VLP Influenza Vaccine in Adults | Biotech Hunter | Biotech Hunter